Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney Cancer Targeted Therapy Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Tyrosine Kinase Inhibitors
1.2.3 mTOR Inhibitors
1.2.4 EGFR Inhibitors
1.2.5 Anti-VEGF Monoclonal Antibody
1.3 Market by Application
1.3.1 Global Kidney Cancer Targeted Therapy Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Renal Cell Cancer
1.3.3 Renal Pelvis Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Kidney Cancer Targeted Therapy Market Perspective (2024-2034)
2.2 Kidney Cancer Targeted Therapy Growth Trends by Region
2.2.1 Global Kidney Cancer Targeted Therapy Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Kidney Cancer Targeted Therapy Historic Market Size by Region (2024-2024)
2.2.3 Kidney Cancer Targeted Therapy Forecasted Market Size by Region (2024-2034)
2.3 Kidney Cancer Targeted Therapy Market Dynamics
2.3.1 Kidney Cancer Targeted Therapy Industry Trends
2.3.2 Kidney Cancer Targeted Therapy Market Drivers
2.3.3 Kidney Cancer Targeted Therapy Market Challenges
2.3.4 Kidney Cancer Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kidney Cancer Targeted Therapy Players by Revenue
3.1.1 Global Top Kidney Cancer Targeted Therapy Players by Revenue (2024-2024)
3.1.2 Global Kidney Cancer Targeted Therapy Revenue Market Share by Players (2024-2024)
3.2 Global Kidney Cancer Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Kidney Cancer Targeted Therapy Revenue
3.4 Global Kidney Cancer Targeted Therapy Market Concentration Ratio
3.4.1 Global Kidney Cancer Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Targeted Therapy Revenue in 2022
3.5 Kidney Cancer Targeted Therapy Key Players Head office and Area Served
3.6 Key Players Kidney Cancer Targeted Therapy Product Solution and Service
3.7 Date of Enter into Kidney Cancer Targeted Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Kidney Cancer Targeted Therapy Breakdown Data by Type
4.1 Global Kidney Cancer Targeted Therapy Historic Market Size by Type (2024-2024)
4.2 Global Kidney Cancer Targeted Therapy Forecasted Market Size by Type (2024-2034)
5 Kidney Cancer Targeted Therapy Breakdown Data by Application
5.1 Global Kidney Cancer Targeted Therapy Historic Market Size by Application (2024-2024)
5.2 Global Kidney Cancer Targeted Therapy Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Kidney Cancer Targeted Therapy Market Size (2024-2034)
6.2 North America Kidney Cancer Targeted Therapy Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Kidney Cancer Targeted Therapy Market Size by Country (2024-2024)
6.4 North America Kidney Cancer Targeted Therapy Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Kidney Cancer Targeted Therapy Market Size (2024-2034)
7.2 Europe Kidney Cancer Targeted Therapy Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Kidney Cancer Targeted Therapy Market Size by Country (2024-2024)
7.4 Europe Kidney Cancer Targeted Therapy Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Kidney Cancer Targeted Therapy Market Size (2024-2034)
8.2 Asia-Pacific Kidney Cancer Targeted Therapy Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Kidney Cancer Targeted Therapy Market Size by Region (2024-2024)
8.4 Asia-Pacific Kidney Cancer Targeted Therapy Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Kidney Cancer Targeted Therapy Market Size (2024-2034)
9.2 Latin America Kidney Cancer Targeted Therapy Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Kidney Cancer Targeted Therapy Market Size by Country (2024-2024)
9.4 Latin America Kidney Cancer Targeted Therapy Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kidney Cancer Targeted Therapy Market Size (2024-2034)
10.2 Middle East & Africa Kidney Cancer Targeted Therapy Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Kidney Cancer Targeted Therapy Market Size by Country (2024-2024)
10.4 Middle East & Africa Kidney Cancer Targeted Therapy Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Kidney Cancer Targeted Therapy Introduction
11.1.4 Merck Revenue in Kidney Cancer Targeted Therapy Business (2024-2024)
11.1.5 Merck Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Kidney Cancer Targeted Therapy Introduction
11.2.4 Novartis Revenue in Kidney Cancer Targeted Therapy Business (2024-2024)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Kidney Cancer Targeted Therapy Introduction
11.3.4 Pfizer Revenue in Kidney Cancer Targeted Therapy Business (2024-2024)
11.3.5 Pfizer Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Kidney Cancer Targeted Therapy Introduction
11.4.4 Roche Revenue in Kidney Cancer Targeted Therapy Business (2024-2024)
11.4.5 Roche Recent Development
11.5 Amgen
11.5.1 Amgen Company Detail
11.5.2 Amgen Business Overview
11.5.3 Amgen Kidney Cancer Targeted Therapy Introduction
11.5.4 Amgen Revenue in Kidney Cancer Targeted Therapy Business (2024-2024)
11.5.5 Amgen Recent Development
11.6 Aveo Pharmaceuticals
11.6.1 Aveo Pharmaceuticals Company Detail
11.6.2 Aveo Pharmaceuticals Business Overview
11.6.3 Aveo Pharmaceuticals Kidney Cancer Targeted Therapy Introduction
11.6.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Targeted Therapy Business (2024-2024)
11.6.5 Aveo Pharmaceuticals Recent Development
11.7 Exelixis
11.7.1 Exelixis Company Detail
11.7.2 Exelixis Business Overview
11.7.3 Exelixis Kidney Cancer Targeted Therapy Introduction
11.7.4 Exelixis Revenue in Kidney Cancer Targeted Therapy Business (2024-2024)
11.7.5 Exelixis Recent Development
11.8 Bayer
11.8.1 Bayer Company Detail
11.8.2 Bayer Business Overview
11.8.3 Bayer Kidney Cancer Targeted Therapy Introduction
11.8.4 Bayer Revenue in Kidney Cancer Targeted Therapy Business (2024-2024)
11.8.5 Bayer Recent Development
11.9 Eisai
11.9.1 Eisai Company Detail
11.9.2 Eisai Business Overview
11.9.3 Eisai Kidney Cancer Targeted Therapy Introduction
11.9.4 Eisai Revenue in Kidney Cancer Targeted Therapy Business (2024-2024)
11.9.5 Eisai Recent Development
11.10 Wyeth
11.10.1 Wyeth Company Detail
11.10.2 Wyeth Business Overview
11.10.3 Wyeth Kidney Cancer Targeted Therapy Introduction
11.10.4 Wyeth Revenue in Kidney Cancer Targeted Therapy Business (2024-2024)
11.10.5 Wyeth Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Kidney Cancer Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Tyrosine Kinase Inhibitors
Table 3. Key Players of mTOR Inhibitors
Table 4. Key Players of EGFR Inhibitors
Table 5. Key Players of Anti-VEGF Monoclonal Antibody
Table 6. Global Kidney Cancer Targeted Therapy Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 7. Global Kidney Cancer Targeted Therapy Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 8. Global Kidney Cancer Targeted Therapy Market Size by Region (2024-2024) & (US$ Million)
Table 9. Global Kidney Cancer Targeted Therapy Market Share by Region (2024-2024)
Table 10. Global Kidney Cancer Targeted Therapy Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Kidney Cancer Targeted Therapy Market Share by Region (2024-2034)
Table 12. Kidney Cancer Targeted Therapy Market Trends
Table 13. Kidney Cancer Targeted Therapy Market Drivers
Table 14. Kidney Cancer Targeted Therapy Market Challenges
Table 15. Kidney Cancer Targeted Therapy Market Restraints
Table 16. Global Kidney Cancer Targeted Therapy Revenue by Players (2024-2024) & (US$ Million)
Table 17. Global Kidney Cancer Targeted Therapy Market Share by Players (2024-2024)
Table 18. Global Top Kidney Cancer Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Targeted Therapy as of 2022)
Table 19. Ranking of Global Top Kidney Cancer Targeted Therapy Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Kidney Cancer Targeted Therapy Revenue (CR5 and HHI) & (2024-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Kidney Cancer Targeted Therapy Product Solution and Service
Table 23. Date of Enter into Kidney Cancer Targeted Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Kidney Cancer Targeted Therapy Market Size by Type (2024-2024) & (US$ Million)
Table 26. Global Kidney Cancer Targeted Therapy Revenue Market Share by Type (2024-2024)
Table 27. Global Kidney Cancer Targeted Therapy Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Kidney Cancer Targeted Therapy Revenue Market Share by Type (2024-2034)
Table 29. Global Kidney Cancer Targeted Therapy Market Size by Application (2024-2024) & (US$ Million)
Table 30. Global Kidney Cancer Targeted Therapy Revenue Market Share by Application (2024-2024)
Table 31. Global Kidney Cancer Targeted Therapy Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Kidney Cancer Targeted Therapy Revenue Market Share by Application (2024-2034)
Table 33. North America Kidney Cancer Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 34. North America Kidney Cancer Targeted Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 35. North America Kidney Cancer Targeted Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Kidney Cancer Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 37. Europe Kidney Cancer Targeted Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 38. Europe Kidney Cancer Targeted Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Kidney Cancer Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 40. Asia-Pacific Kidney Cancer Targeted Therapy Market Size by Region (2024-2024) & (US$ Million)
Table 41. Asia-Pacific Kidney Cancer Targeted Therapy Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Kidney Cancer Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 43. Latin America Kidney Cancer Targeted Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 44. Latin America Kidney Cancer Targeted Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Kidney Cancer Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 46. Middle East & Africa Kidney Cancer Targeted Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 47. Middle East & Africa Kidney Cancer Targeted Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 48. Merck Company Detail
Table 49. Merck Business Overview
Table 50. Merck Kidney Cancer Targeted Therapy Product
Table 51. Merck Revenue in Kidney Cancer Targeted Therapy Business (2024-2024) & (US$ Million)
Table 52. Merck Recent Development
Table 53. Novartis Company Detail
Table 54. Novartis Business Overview
Table 55. Novartis Kidney Cancer Targeted Therapy Product
Table 56. Novartis Revenue in Kidney Cancer Targeted Therapy Business (2024-2024) & (US$ Million)
Table 57. Novartis Recent Development
Table 58. Pfizer Company Detail
Table 59. Pfizer Business Overview
Table 60. Pfizer Kidney Cancer Targeted Therapy Product
Table 61. Pfizer Revenue in Kidney Cancer Targeted Therapy Business (2024-2024) & (US$ Million)
Table 62. Pfizer Recent Development
Table 63. Roche Company Detail
Table 64. Roche Business Overview
Table 65. Roche Kidney Cancer Targeted Therapy Product
Table 66. Roche Revenue in Kidney Cancer Targeted Therapy Business (2024-2024) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Amgen Company Detail
Table 69. Amgen Business Overview
Table 70. Amgen Kidney Cancer Targeted Therapy Product
Table 71. Amgen Revenue in Kidney Cancer Targeted Therapy Business (2024-2024) & (US$ Million)
Table 72. Amgen Recent Development
Table 73. Aveo Pharmaceuticals Company Detail
Table 74. Aveo Pharmaceuticals Business Overview
Table 75. Aveo Pharmaceuticals Kidney Cancer Targeted Therapy Product
Table 76. Aveo Pharmaceuticals Revenue in Kidney Cancer Targeted Therapy Business (2024-2024) & (US$ Million)
Table 77. Aveo Pharmaceuticals Recent Development
Table 78. Exelixis Company Detail
Table 79. Exelixis Business Overview
Table 80. Exelixis Kidney Cancer Targeted Therapy Product
Table 81. Exelixis Revenue in Kidney Cancer Targeted Therapy Business (2024-2024) & (US$ Million)
Table 82. Exelixis Recent Development
Table 83. Bayer Company Detail
Table 84. Bayer Business Overview
Table 85. Bayer Kidney Cancer Targeted Therapy Product
Table 86. Bayer Revenue in Kidney Cancer Targeted Therapy Business (2024-2024) & (US$ Million)
Table 87. Bayer Recent Development
Table 88. Eisai Company Detail
Table 89. Eisai Business Overview
Table 90. Eisai Kidney Cancer Targeted Therapy Product
Table 91. Eisai Revenue in Kidney Cancer Targeted Therapy Business (2024-2024) & (US$ Million)
Table 92. Eisai Recent Development
Table 93. Wyeth Company Detail
Table 94. Wyeth Business Overview
Table 95. Wyeth Kidney Cancer Targeted Therapy Product
Table 96. Wyeth Revenue in Kidney Cancer Targeted Therapy Business (2024-2024) & (US$ Million)
Table 97. Wyeth Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kidney Cancer Targeted Therapy Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Kidney Cancer Targeted Therapy Market Share by Type: 2022 VS 2034
Figure 3. Tyrosine Kinase Inhibitors Features
Figure 4. mTOR Inhibitors Features
Figure 5. EGFR Inhibitors Features
Figure 6. Anti-VEGF Monoclonal Antibody Features
Figure 7. Global Kidney Cancer Targeted Therapy Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Kidney Cancer Targeted Therapy Market Share by Application: 2022 VS 2034
Figure 9. Renal Cell Cancer Case Studies
Figure 10. Renal Pelvis Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. Kidney Cancer Targeted Therapy Report Years Considered
Figure 13. Global Kidney Cancer Targeted Therapy Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 14. Global Kidney Cancer Targeted Therapy Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global Kidney Cancer Targeted Therapy Market Share by Region: 2022 VS 2034
Figure 16. Global Kidney Cancer Targeted Therapy Market Share by Players in 2022
Figure 17. Global Top Kidney Cancer Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Targeted Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Kidney Cancer Targeted Therapy Revenue in 2022
Figure 19. North America Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 20. North America Kidney Cancer Targeted Therapy Market Share by Country (2024-2034)
Figure 21. United States Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 22. Canada Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. Europe Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. Europe Kidney Cancer Targeted Therapy Market Share by Country (2024-2034)
Figure 25. Germany Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. France Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. U.K. Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Italy Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Russia Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Nordic Countries Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Asia-Pacific Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Asia-Pacific Kidney Cancer Targeted Therapy Market Share by Region (2024-2034)
Figure 33. China Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. Japan Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. South Korea Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. Southeast Asia Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. India Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. Australia Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Latin America Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Latin America Kidney Cancer Targeted Therapy Market Share by Country (2024-2034)
Figure 41. Mexico Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Brazil Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Middle East & Africa Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Middle East & Africa Kidney Cancer Targeted Therapy Market Share by Country (2024-2034)
Figure 45. Turkey Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 46. Saudi Arabia Kidney Cancer Targeted Therapy Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 47. Merck Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2024-2024)
Figure 48. Novartis Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2024-2024)
Figure 49. Pfizer Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2024-2024)
Figure 50. Roche Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2024-2024)
Figure 51. Amgen Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2024-2024)
Figure 52. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2024-2024)
Figure 53. Exelixis Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2024-2024)
Figure 54. Bayer Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2024-2024)
Figure 55. Eisai Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2024-2024)
Figure 56. Wyeth Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2024-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed